These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 19732305)

  • 1. Testosterone partially ameliorates metabolic profile and erectile responsiveness to PDE5 inhibitors in an animal model of male metabolic syndrome.
    Filippi S; Vignozzi L; Morelli A; Chavalmane AK; Sarchielli E; Fibbi B; Saad F; Sandner P; Ruggiano P; Vannelli GB; Mannucci E; Maggi M
    J Sex Med; 2009 Dec; 6(12):3274-88. PubMed ID: 19732305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Testosterone restores diabetes-induced erectile dysfunction and sildenafil responsiveness in two distinct animal models of chemical diabetes.
    Zhang XH; Filippi S; Morelli A; Vignozzi L; Luconi M; Donati S; Forti G; Maggi M
    J Sex Med; 2006 Mar; 3(2):253-64; discussion 264-5, author reply 265-6. PubMed ID: 16490018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonalcoholic steatohepatitis as a novel player in metabolic syndrome-induced erectile dysfunction: an experimental study in the rabbit.
    Vignozzi L; Filippi S; Comeglio P; Cellai I; Sarchielli E; Morelli A; Rastrelli G; Maneschi E; Galli A; Vannelli GB; Saad F; Mannucci E; Adorini L; Maggi M
    Mol Cell Endocrinol; 2014 Mar; 384(1-2):143-54. PubMed ID: 24486698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Testosterone and farnesoid X receptor agonist INT-747 counteract high fat diet-induced bladder alterations in a rabbit model of metabolic syndrome.
    Morelli A; Comeglio P; Filippi S; Sarchielli E; Cellai I; Vignozzi L; Yehiely-Cohen R; Maneschi E; Gacci M; Carini M; Adorini L; Vannelli GB; Maggi M
    J Steroid Biochem Mol Biol; 2012 Oct; 132(1-2):80-92. PubMed ID: 22406511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physical activity counteracts metabolic syndrome-induced hypogonadotropic hypogonadism and erectile dysfunction in the rabbit.
    Morelli A; Filippi S; Comeglio P; Sarchielli E; Cellai I; Pallecchi M; Bartolucci G; Danza G; Rastrelli G; Corno C; Guarnieri G; Fuochi E; Vignozzi L; Maggi M
    Am J Physiol Endocrinol Metab; 2019 Mar; 316(3):E519-E535. PubMed ID: 30645174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cavernous neurotomy in the rat is associated with the onset of an overt condition of hypogonadism.
    Vignozzi L; Filippi S; Morelli A; Marini M; Chavalmane A; Fibbi B; Silvestrini E; Mancina R; Carini M; Vannelli GB; Forti G; Maggi M
    J Sex Med; 2009 May; 6(5):1270-83. PubMed ID: 19210708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Testosterone therapy in erectile dysfunction and hypogonadism.
    Shabsigh R
    J Sex Med; 2005 Nov; 2(6):785-92. PubMed ID: 16422803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanism of action of phosphodiesterase type 5 inhibition in metabolic syndrome-associated prostate alterations: an experimental study in the rabbit.
    Morelli A; Comeglio P; Filippi S; Sarchielli E; Vignozzi L; Maneschi E; Cellai I; Gacci M; Lenzi A; Vannelli GB; Maggi M
    Prostate; 2013 Mar; 73(4):428-41. PubMed ID: 22996758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Androgens regulate phosphodiesterase type 5 expression and functional activity in corpora cavernosa.
    Morelli A; Filippi S; Mancina R; Luconi M; Vignozzi L; Marini M; Orlando C; Vannelli GB; Aversa A; Natali A; Forti G; Giorgi M; Jannini EA; Ledda F; Maggi M
    Endocrinology; 2004 May; 145(5):2253-63. PubMed ID: 14764637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Farnesoid X receptor activation improves erectile function in animal models of metabolic syndrome and diabetes.
    Vignozzi L; Morelli A; Filippi S; Comeglio P; Chavalmane AK; Marchetta M; Toce M; Yehiely-Cohen R; Vannelli GB; Adorini L; Maggi M
    J Sex Med; 2011 Jan; 8(1):57-77. PubMed ID: 20955313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estrogen mediates metabolic syndrome-induced erectile dysfunction: a study in the rabbit.
    Vignozzi L; Filippi S; Comeglio P; Cellai I; Morelli A; Marchetta M; Maggi M
    J Sex Med; 2014 Dec; 11(12):2890-902. PubMed ID: 25243860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atorvastatin ameliorates sildenafil-induced penile erections in experimental diabetes by inhibiting diabetes-induced RhoA/Rho-kinase signaling hyperactivation.
    Morelli A; Chavalmane AK; Filippi S; Fibbi B; Silvestrini E; Sarchielli E; Zhang XH; Vignozzi L; Vannelli GB; Forti G; Maggi M
    J Sex Med; 2009 Jan; 6(1):91-106. PubMed ID: 19170840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endothelial antioxidant administration ameliorates the erectile response to PDE5 regardless of the extension of the atherosclerotic process.
    Vicari E; La Vignera S; Condorelli R; Calogero AE
    J Sex Med; 2010 Mar; 7(3):1247-53. PubMed ID: 19674252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Testosterone protects from metabolic syndrome-associated prostate inflammation: an experimental study in rabbit.
    Vignozzi L; Morelli A; Sarchielli E; Comeglio P; Filippi S; Cellai I; Maneschi E; Serni S; Gacci M; Carini M; Piccinni MP; Saad F; Adorini L; Vannelli GB; Maggi M
    J Endocrinol; 2012 Jan; 212(1):71-84. PubMed ID: 22010203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Negative impact of metabolic syndrome on the responsiveness to sildenafil in Japanese men.
    Suetomi T; Kawai K; Hinotsu S; Joraku A; Oikawa T; Sekido N; Miyanaga N; Shimazui T; Akaza H
    J Sex Med; 2008 Jun; 5(6):1443-50. PubMed ID: 18208503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In-vitro effects of PDE5 inhibitor and statin treatment on the contractile responses of experimental MetS rabbit's cavernous smooth muscle.
    Erden Y; Korgalı E; Dundar G; Ayan S; Gokce G; Yildirim S; Gultekin EY
    Arch Ital Urol Androl; 2014 Mar; 86(1):33-8. PubMed ID: 24704929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The evolving role of testosterone in the treatment of erectile dysfunction.
    Shabsigh R; Rajfer J; Aversa A; Traish AM; Yassin A; Kalinchenko SY; Buvat J
    Int J Clin Pract; 2006 Sep; 60(9):1087-92. PubMed ID: 16939550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SOP conservative (medical and mechanical) treatment of erectile dysfunction.
    Porst H; Burnett A; Brock G; Ghanem H; Giuliano F; Glina S; Hellstrom W; Martin-Morales A; Salonia A; Sharlip I;
    J Sex Med; 2013 Jan; 10(1):130-71. PubMed ID: 23343170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metformin in vitro and in vivo increases adenosine signaling in rabbit corpora cavernosa.
    Vignozzi L; Filippi S; Comeglio P; Cellai I; Morelli A; Rastrelli G; Maneschi E; Mannucci E; Maggi M
    J Sex Med; 2014 Jul; 11(7):1694-708. PubMed ID: 24844317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo and in vitro response of corpus cavernosum to phosphodiesterase-5 inhibition in the hypercholesterolaemic rabbit.
    Firoozi F; Longhurst PA; White MD
    BJU Int; 2005 Jul; 96(1):164-8. PubMed ID: 15963142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.